Total Payments
$738,392
2024 Payments
$134,640
Companies
54
Transactions
2,147
Medicare Patients
11,732
Medicare Billing
$778,269
Payment Breakdown by Category
Other$319,044 (43.2%)
Consulting$318,778 (43.2%)
Food & Beverage$52,904 (7.2%)
Research$28,422 (3.8%)
Travel$18,569 (2.5%)
Education$665.87 (0.1%)
Gifts$8.03 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $318,778 | 104 | 43.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $253,076 | 102 | 34.3% |
| Food and Beverage | $52,904 | 1,764 | 7.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $40,810 | 15 | 5.5% |
| Unspecified | $28,422 | 10 | 3.8% |
| Honoraria | $25,088 | 17 | 3.4% |
| Travel and Lodging | $18,569 | 116 | 2.5% |
| Education | $665.87 | 17 | 0.1% |
| Grant | $70.00 | 1 | 0.0% |
| Gift | $8.03 | 1 | 0.0% |
Payments by Type
General
$709,969
2,137 transactions
Research
$28,422
10 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ortho Dermatologics, a division of Bausch Health US, LLC | $115,816 | 203 | $0 (2024) |
| ABBVIE INC. | $111,876 | 395 | $0 (2024) |
| Galderma Laboratories, L.P. | $103,720 | 142 | $0 (2024) |
| UCB, Inc. | $58,285 | 163 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $54,965 | 105 | $0 (2024) |
| GENZYME CORPORATION | $38,605 | 92 | $0 (2024) |
| Biofrontera Inc. | $32,561 | 28 | $0 (2024) |
| LEO Pharma Inc. | $25,172 | 65 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $22,680 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $20,886 | 157 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $134,640 | 369 | ABBVIE INC. ($25,236) |
| 2023 | $103,455 | 345 | Galderma Laboratories, L.P. ($24,058) |
| 2022 | $76,776 | 289 | ABBVIE INC. ($14,760) |
| 2021 | $70,081 | 154 | Galderma Laboratories, L.P. ($21,013) |
| 2020 | $86,678 | 136 | Ortho Dermatologics, a division of Bausch Health US, LLC ($18,575) |
| 2019 | $94,247 | 349 | Ortho Dermatologics, a division of Bausch Health US, LLC ($22,157) |
| 2018 | $124,643 | 299 | Ortho Dermatologics, a division of Bausch Health US, LLC ($59,523) |
| 2017 | $47,872 | 206 | Valeant Pharmaceuticals North America LLC ($19,254) |
All Payment Transactions
2,147 individual payment records from CMS Open Payments — Page 1 of 86
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug), DUOBRII, TARGRETIN | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Dermatology | ||||||
| 12/23/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug), DUOBRII, TARGRETIN | Food and Beverage | In-kind items and services | $3.94 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,253.00 | General |
| Category: Immunology | ||||||
| 12/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $131.01 | General |
| Category: Immunology | ||||||
| 12/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $33.50 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: DERMATOLOGY | ||||||
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.41 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $101.49 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.12 | General |
| Category: Immunology | ||||||
| 12/10/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: Inflammation & Immunology | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $3.53 | General |
| Category: Immunology | ||||||
| 12/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.88 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $8.92 | General |
| Category: Dermatology | ||||||
| 12/06/2024 | Biofrontera Inc. | BF-RhodoLED (Device), Ameluz, RhodoLED XL | Consulting Fee | Cash or cash equivalent | $1,312.50 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug), SILIQ, ARAZLO | Food and Beverage | In-kind items and services | $86.18 | General |
| Category: Dermatology | ||||||
| 12/02/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $43.58 | General |
| Category: Dermatology | ||||||
| 12/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $34.88 | General |
| 11/25/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $48.98 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: Immunology | ||||||
| 11/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $3.06 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLECONTROLLED, PARALLEL-GROUP, CLINICAL STUDY COMPARING THE EFFICACY AND SAFETY OF IDP-126 GEL IN THE TREATMENT OF ACNE VULGARIS | Bausch Health US, LLC | $17,400 | 6 |
| EFFICACY AND SAFETY OF ADAPALENE 0.35BENZOYL PEROXIDE 2.5 GEL PLUS DOXYCYCLINE IN SEVERE INFLAMMATORY ACNE NON-NODULOCYSTIC SUBJECTS | Galderma Laboratories, L.P. | $5,904 | 1 |
| A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLECONTROLLED, PARALLEL-GROUP, CLINICAL STUDY COMPARING THE EFFICACY AND SAFETY OF IDP-126 GEL IN THE TREATMENT OF ACNE VULGARIS | Valeant Pharmaceuticals North America LLC | $3,594 | 2 |
| CC-10004-PSOR-008 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects with Moderate to Severe Plaque Psoriasis | Celgene Corporation | $1,524 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 3,296 | 6,813 | $910,264 | $229,881 |
| 2022 | 18 | 3,261 | 6,596 | $788,522 | $228,061 |
| 2021 | 18 | 2,440 | 5,149 | $572,522 | $158,045 |
| 2020 | 18 | 2,735 | 10,607 | $572,353 | $162,282 |
Total Patients
11,732
Total Services
29,165
Medicare Billing
$778,269
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 976 | 1,486 | $344,324 | $86,273 | 25.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 624 | 823 | $143,122 | $31,546 | 22.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 344 | 404 | $106,077 | $27,400 | 25.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 189 | 204 | $61,043 | $16,217 | 26.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 500 | 3,051 | $53,809 | $14,860 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 106 | 158 | $52,174 | $13,505 | 25.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 168 | 168 | $49,888 | $12,101 | 24.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 48 | 53 | $23,525 | $6,792 | 28.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 39 | 43 | $19,604 | $5,840 | 29.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 86 | 143 | $18,884 | $5,595 | 29.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 64 | 68 | $9,837 | $2,488 | 25.3% |
| 69100 | Biopsy of ear | Office | 2023 | 25 | 25 | $6,292 | $1,640 | 26.1% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 14 | 15 | $4,527 | $1,407 | 31.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $5,160 | $1,323 | 25.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 11 | 13 | $4,908 | $1,232 | 25.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 13 | 13 | $2,641 | $592.72 | 22.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 47 | $1,730 | $386.09 | 22.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 40 | 55 | $731.00 | $353.50 | 48.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 12 | 14 | $1,933 | $323.16 | 16.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 19 | $56.67 | $7.63 | 13.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 975 | 1,417 | $294,073 | $85,033 | 28.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 597 | 797 | $122,724 | $31,023 | 25.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 342 | 400 | $94,309 | $26,806 | 28.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 185 | 208 | $54,442 | $16,828 | 30.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 492 | 2,942 | $45,318 | $15,057 | 33.2% |
About Dr. Jonathan Weiss, MD
Dr. Jonathan Weiss, MD is a Dermatology healthcare provider based in Snellville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619913712.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Weiss, MD has received a total of $738,392 in payments from pharmaceutical and medical device companies, with $134,640 received in 2024. These payments were reported across 2,147 transactions from 54 companies. The most common payment nature is "Consulting Fee" ($318,778).
As a Medicare-enrolled provider, Weiss has provided services to 11,732 Medicare beneficiaries, totaling 29,165 services with total Medicare billing of $778,269. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Snellville, GA
- Active Since 06/20/2006
- Last Updated 07/08/2007
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1619913712
Products in Payments
- DUPIXENT (Biological) $76,199
- AKLIEF (Drug) $58,523
- SILIQ (Drug) $55,714
- SKYRIZI (Biological) $54,408
- ONEXTON (Drug) $33,600
- AMELUZ (Drug) $31,131
- Humira (Biological) $24,143
- Cimzia (Drug) $22,312
- Zoryve (Drug) $21,714
- COSENTYX (Biological) $19,579
- ADBRY (Biological) $14,819
- ALTRENO (Drug) $14,303
- Bimzelx (Biological) $14,161
- EPIDUO FORTE (Drug) $13,646
- ARAZLO (Drug) $13,623
- CIBINQO (Drug) $12,179
- RINVOQ (Biological) $11,338
- VTAMA (Drug) $11,288
- DUOBRII (Drug) $10,463
- DUPIXENT DUPILUMAB INJECTION (Biological) $8,426
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Snellville
Dr. Jessica Mercer, M.d, M.D
Dermatology — Payments: $97,770
Dermatology $97,770
Dr. Alia Brown, M.d, M.D
Dermatology — Payments: $49,812
Dermatology $49,812
Brittany Dupree, Np-C, NP-C
Dermatology — Payments: $19,620
Dermatology $19,620
Joel Shavin, Md, MD
Dermatology — Payments: $6,941
Dermatology $6,941
Maria Paz Henkels
Dermatology — Payments: $6,331
Dermatology $6,331
Keith Wright, Md, MD
Dermatology — Payments: $4,739
Dermatology $4,739